2017
DOI: 10.1080/09638237.2017.1417562
|View full text |Cite
|
Sign up to set email alerts
|

The economic cost of treatment-resistant depression in patients referred to a specialist service

Abstract: Severe forms of TRD are associated with high costs in which unpaid care and lost work predominate. Treatments that improve functioning may reduce the large degree of burden.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
30
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(32 citation statements)
references
References 34 publications
2
30
0
Order By: Relevance
“…Associated diagnoses in patients who are frequently considered difficult include substance abusers or psychotic patients (e.g., Sellers et al, ). Of particular interest for this study, treatment‐resistant depression and depression in the context of personality vulnerabilities may often trigger the labeling of a patient as difficult, given that these patients will not typically respond to first‐line psychotherapy or pharmacology (Greden, ; McCrone et al, ). In nonspecialized treatment settings, these clients present many problems, including, frequent comorbidities and multiple emotional demands on therapists and treatment teams.…”
Section: Introductionmentioning
confidence: 99%
“…Associated diagnoses in patients who are frequently considered difficult include substance abusers or psychotic patients (e.g., Sellers et al, ). Of particular interest for this study, treatment‐resistant depression and depression in the context of personality vulnerabilities may often trigger the labeling of a patient as difficult, given that these patients will not typically respond to first‐line psychotherapy or pharmacology (Greden, ; McCrone et al, ). In nonspecialized treatment settings, these clients present many problems, including, frequent comorbidities and multiple emotional demands on therapists and treatment teams.…”
Section: Introductionmentioning
confidence: 99%
“…We believe that the present results might be of broader interest: First, in terms of the costs for the companies (hiring new employee and absent or less productive employees) and for the employees (health and changing the job). Specifically, costs in employees being less productive or absent will result in several high costs per employee (26,27,30,57). Second, the public health cost should also be mentioned here although we did not calculate the costs.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies (24)(25)(26)(27) show that, compared to healthy individuals, individuals with MDD are at an increased risk to lose their current job position (24,25,27), to have more difficulties to go back to their workplace (24,25,27), to find a new job, once they have been dismissed, and to keep their job position, when they return to their job after a period of illness-related unemployment. Furthermore, data on health costs show that, compared to an accident-related absence from work, depression-related absence from work cause higher economic burden for the individual (25,27), the employer (27)(28)(29), and the public (24,26,27,30). In addition, losing a job position or experiencing difficulties to go back to work turned out to be a risk factor for further relapses of MDD (24).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Epidemiological surveys have repeatedly indicated a high lifetime prevalence of this illness, amounting to 6.7% of the population worldwide [ 2 ]. The costs of MDD to society, in terms of personal and familial suffering and health care consumption, are high [ 3 , 4 ]. Despite the progress in pharmacopoeia and in psychological therapies, clinicians involved in the management of MDD are regularly faced with clinical situations marked by treatment resistance.…”
Section: Introductionmentioning
confidence: 99%